CNBG’s Japanese Encephalitis Vaccine Prequalified by WHO

A Japanese encephalitis vaccine produced by China National Biotec Group (CNBG), a subsidiary of state-owned Sinopharm, was prequalified by the World Health Organization. It is the first JE vaccine to be prequalified for use in children and the first-ever China vaccine to be granted WHO prequalification. The certification allows UN organizations to buy the vaccine and distribute it in less-developed countries. PATH, a nonprofit health organization, assisted CNBG. The agency was very interested in promoting a China vaccine because the low cost would facilitate distribution. More details.... Share this with colleagues: // //